IXICO is dedicated to delivering insights in neuroscience to help transform the advancement of investigational therapies for neurological diseases, such Alzheimer's disease, Parkinson’s disease and Huntington's disease. The Company's purpose is to advance medicine and human health by turning biomarker data into clinically meaningful information, supporting pharmaceutical companies across all phases of CNS clinical research. IXICO's goal is to be a leading advocate of artificial intelligence in medical image and broader biomarker analysis. IXICO has developed and deployed breakthrough data analytics, at scale, through its remote access technology platform, to improve the return on investment in drug development and reduce risk and uncertainty in clinical trials for the Company's pharmaceutical clients as they develop novel solutions for high unmet challenges in the space of neurodegenerative diseases .